Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Index funds have fees that can trim gains. This guide compares Worth It Index Funds Vs Etfs Costs and why the cheaper option often wins over time.
23,596 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Retail traders are rushing into oil bets as Iran-related tensions push prices higher, driving big fund inflows while ...
As July 2026 unfolds, the two JPMorgan income ETFs clash over safety versus yield. This piece weighs performance, pay...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Bitcoin’s below $80K could be a temporary pause rather than a lasting trend. This article breaks down STRC cycles, ET...
A profitability-screened small-cap ETF is gaining attention as markets trend toward earnings power. The fund offers a...
Warren Buffett's century-spanning Dow forecast remains a talking point as the index sits in the mid-30,000s in 2026. ...
As Trump claims credit for the market surge, data shows Nvidia-led momentum dominates the gains and market breadth re...
The chip that turned $10k into nearly $20k this year is drawing attention as AI demand and a few megacap chip firms l...
A triple-leveraged note tied to a tech stock basket plunged 18% in a single session, erasing much of a year’s gains a...
The S&P 500 tests major support as volatility eases and a fresh buy signal emerges. Traders weigh a possible near-ter...
A contrarian, anti-ESG energy ETF seeks to profit from oil-price volatility by concentrating on top fossil-fuel produ...